The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 31, 2018
Filed:
Aug. 20, 2015
Applicant:
Celgene Corporation, Summit, NJ (US);
Inventors:
Anjan Thakurta, Basking Ridge, NJ (US);
Mohamed Hussein, Odessa, FL (US);
Christian Jacques, Hamburg, NJ (US);
Assignee:
Celgene Corporation, Summit, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/454 (2006.01); A61K 31/5377 (2006.01); A61K 31/573 (2006.01); A61K 31/69 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01); A61K 35/28 (2015.01);
U.S. Cl.
CPC ...
A61K 31/454 (2013.01); A61K 31/5377 (2013.01); A61K 31/573 (2013.01); A61K 31/69 (2013.01); C07K 16/2803 (2013.01); A61K 35/28 (2013.01); A61K 2039/545 (2013.01); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01);
Abstract
Methods of treating, preventing and/or managing multiple myeloma are disclosed. Specific methods encompass the administration of an immunomodulatory compound, e.g., lenalidomide or pomalidomide with an anti-CS1 antibody, e.g., elotuzumab in patients who have received autologous stem cell transplantation.